The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.

Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.

The halt occurred following this morning's arrest of CEO Martin Shkreli following allegations of securities fraud.

Short Sales Trader Talk Trading Halts

Martin Shkreli Was Apparently Live Streaming When FBI Agents CalledDecember 17, 2015 3:37 PM Photo of Martin Shkreli Being Arrested by FBI AgentsDecember 17, 2015 11:25 AM Shkreli Indictment Document Posted (KBIO)December 17, 2015 11:00 AM NASDAQ Affirms Trading Halt on KaloBios Pharma (KBIO)December 17, 2015 10:42 AM Nasdaq Halts KaloBios Pharmaceuticals, Inc.December 17, 2015 10:41 AM Martin Shkreli, Evan Greebel accused of 3 fraud schemes dating back to 2009 - BloombergDecember 17, 2015 9:45 AM New York Lawyer Evan Greebel arrested in Martin Shkreli investigation - BloombergDecember 17, 2015 7:19 AM KaloBios Pharma (KBIO) trading halted for infoDecember 17, 2015 6:48 AM